Philip Hopcroft

Philip Hopcroft is an Associate Principal Scientist at AstraZeneca. He graduated initially at Leeds University before obtaining his Masters at Edinburgh University. Post that he worked at the University of Manchester for several years in the areas of DNA damage and drug metabolism, prior to joining AstraZeneca in 2001 in the Cancer and Infection department. Focusing on Oncology projects spanning the early phase drug discovery timeline, from Hit Identification to Lead Optimisation and Candidate Drug nomination. During this time he gained extensive experience on the use of LCMS looking at cell metabolism and began his journey into automation. On formation of the Discovery Sciences department within AZ he has focused on cell assay development, profiling and mode of action studies, with particular specialism/interest in high content imaging and automation. He leads the UK in driving the strategy/use/uptake of automation in DMTA assays in APCS (DS) and steers a cross functional team of auto